4//SEC Filing
Mercier Johanna 4
Accession 0001782135-25-000015
CIK 0000882095other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 6:25 PM ET
Size
8.3 KB
Accession
0001782135-25-000015
Insider Transaction Report
Form 4
Mercier Johanna
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-10+3,842→ 111,035 total - Tax Payment
Common Stock
2025-12-10$121.34/sh−1,814$220,111→ 109,221 total - Exercise/Conversion
Restricted Stock Unit
2025-12-10−3,842→ 27,674 total→ Common Stock (3,842 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001782135
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 6:25 PM ET
- Size
- 8.3 KB